Recent studies demonstrated an overexpression of CIP2A in several cancer cells [41], such as tumors of the stomach [46], esophagus [47], colon [48] and pancreas [49], renal cell cancer [50] and ovarian and cervical cancer [51,52]. Here, CIP2A is linked to cancer.